UroGen Pharma (URGN) Return on Capital Employed Growth (3y) (2022 - 2026)
UroGen Pharma (URGN) Return on Capital Employed Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -3,782.00 |
| 10 | UroGen Pharma | 2.05 Bn | 1.91 Bn | 46.82 Mn | 1,855.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,855.00 |
| Dec 31, 2025 | -1,223.00 |
| Sep 30, 2025 | -1,977.00 |
| Jun 30, 2025 | -747.00 |
| Mar 31, 2025 | 2,323.00 |
| Dec 31, 2024 | 4,903.00 |
| Sep 30, 2024 | 4,779.00 |
| Jun 30, 2024 | 6,036.00 |
| Mar 31, 2024 | 8,084.00 |
| Dec 31, 2023 | 7,338.00 |
| Sep 30, 2023 | 4,487.00 |
| Jun 30, 2023 | -737.00 |
| Mar 31, 2023 | -620.00 |
| Dec 31, 2022 | -1,698.00 |
| Sep 30, 2022 | -2,365.00 |
| Jun 30, 2022 | -2,184.00 |
| Mar 31, 2022 | -1,997.00 |